Clinical Trial

Clinical Trial Assessing Godex Carnitine Orotate Complex in Nonalcoholic Fatty Liver Disease Patients for Efficacy

Enrolling by Invitation Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated December 1, 2023 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
the purpose of this clinical trial is to assess the efficacy and safety of Orotic Acid Carnitine Complex Capsules (Godex®) in comparison to a placebo control group in patients with Non-Alcoholic Fatty Liver Disease (NAFLD).
Trial Details
NCT Number NCT06152991
Lead Sponsor Yoon Jun Kim
Collaborators: Celltrion Pharm, Inc.
Conditions Non-Alcoholic Fatty Liver Disease
Enrollment 196 participants
Start Date 2023-09-25
Primary Completion 2026-06-30 (estimated)
Study Completion 2027-02-26 (estimated)
Updated on ClinicalTrials.gov 2023-12-01